Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study

Published:2022-11-02 Issue: Volume: Page:1-7
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Cui Dan¹,Hu Xiaomeng²,Shi Li³,Wang Dongchang⁴,Chen Gang⁴

Affiliation:

1. Department of Tuberculosis, Hebei Chest Hospital, Shijiazhuang, China

2. Tuberculosis IV Ward, Wuhan Pulmonary Hospital, Wuhan, China

3. Department of Tuberculosis, Changsha Central Hospital, University of South China, Changsha, China

4. Department of Respiratory Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, China

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2022.2136447

Reference29 articles.

1. Tuberculosis and chronic respiratory disease: a systematic review

2. World health organization. Global tuberculosis report 2018. Geneva, Switzerland: World Health Organization; 2018.

3. What will it take to eliminate drug-resistant tuberculosis?

4. Proteomics and Bioinformatics: A Modern Way to Elucidate the Resistome in Mycobacterium tuberculosis

5. Management of drug-resistant tuberculosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment;Pharmaceuticals;2023-11-08

2. Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection;Pharmaceutics;2023-09-30

3. Side effects of drugs used in the treatment of tuberculosis and leprosy;Side Effects of Drugs Annual;2023

4. Linezolid-related AEs in patients with rifampicin-resistant TB;Reactions Weekly;2022-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3